ClinicalTrials.govpublic full text
A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.
head and neck squamous cell carcinoma, low-dose radiotherapy, immunotherapy, targeted therapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 398308
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.